RLAY
Price:
$15.88
Market Cap:
$2.78B
Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administered small molecule designed to inhibit fibroblast growth factor receptor 2 (FGFR2), which is undergoing its initial human trials for patients with advanced or metastatic solid tumors exhibiting FGFR2 alterations; RLY-2608, a leading program targeting mutant phosphoinositide 3 kinase alpha (PI3Ka); and RL...[Read more]
Industry
Biotechnology
IPO Date
2020-07-16
Stock Exchange
NASDAQ
Ticker
RLAY
According to Relay Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Relay Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), RLAY's Dividend Yield was at its highest in in the March 2019 quarter at 0%. The Dividend Yield was at its lowest in in the March 2019 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Relay Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0% | 0% |
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
The current Dividend Yield of Relay Therapeutics, Inc. (RLAY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Relay Therapeutics, Inc.’s Dividend Yield is less than Syndax Pharmaceuticals, Inc. (0%), less than ORIC Pharmaceuticals, Inc. (0%), less than Amylyx Pharmaceuticals, Inc. (0%), less than Inhibrx Biosciences, Inc. (0%), less than Upstream Bio, Inc. (0%), less than Nektar Therapeutics (0%), less than CureVac N.V. (0%), less than Immatics N.V. (0%), less than Sana Biotechnology, Inc. (0%), less than Zenas BioPharma, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $1.68B | |
| 0% | $878.86M | |
| 0% | $1.30B | |
| 0% | $1.37B | |
| 0% | $340.12M | |
| 0% | $1.19B | |
| 0% | $1.05B | |
| 0% | $1.31B | |
| 0% | $876.62M | |
| 0% | $883.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Relay Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Relay Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Relay Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Relay Therapeutics, Inc. (RLAY)?
What is the highest Dividend Yield for Relay Therapeutics, Inc. (RLAY)?
What is the 3-year average Dividend Yield for Relay Therapeutics, Inc. (RLAY)?
What is the 5-year average Dividend Yield for Relay Therapeutics, Inc. (RLAY)?
How does the current Dividend Yield for Relay Therapeutics, Inc. (RLAY) compare to its historical average?